Lydia Beaudette's guest appearances

Lydia Beaudette

Outcomes Rocket

Totally Clinical: Trial Triumphs &amp; Rad Trends

OwlTail

We can build research communities and increase access by helping HCPs navigate the path into clinical research.In this episode, Lydia Beaudette talks about the process of attracting and transforming HCPs into researchers. She discusses the enormous complexity of conducting multiple studies, emphasizing best practices of integrating research into a health system, the benefits of building communities of practice, and the risks and benefits of research for HCPs.Tune in to learn about the challenges and opportunities for clinicians as the clinical research world evolves!Click this link to the show notes, transcript, and resources: outcomesrocket.health

We can build research communities and increase access by helping HCPs navigate the path into clinical research.In this episode, Lydia Beaudette talks about the process of attracting and transforming HCPs into researchers. She discusses the enormous complexity of conducting multiple studies, emphasizing best practices of integrating research into a health system, the benefits of building communities of practice, and the risks and benefits of research for HCPs.Tune in to learn about the challenges and opportunities for clinicians as the clinical research world evolves! Click this link to the show notes, transcript, and resources: <a href="https://outcomesrocket.health/" rel="nofollow" target="_blank">outcomesrocket.health</a>

RC: Successfully Transitioning from HCP to Clinical Researcher with Lydia Beaudette,  Director of Growth and Strategic Partnerships at Centricity Research

Less is more when it comes to sites, especially considering the list of technology staff are expected to use throughout a clinical trial. From the idea of power users to a bottom-up approach, Lydia Beaudette, manager of growth at LMC Manna Research, discusses her role in implementing new technologies for large site networks against the backdrop of COVID-19 as well as what’s essential evaluating solution partners.“If you can get the right fit from the beginning, it can make for a much smoother process. Any technology that can be used intuitively and require minimal training is ideal.”

Less is more when it comes to sites, especially considering the list of technology staff are expected to use throughout a clinical trial. From the idea of power users to a bottom-up approach, <a href="https://www.linkedin.com/in/lydia-beaudette-7178026b/" rel="noreferrer noopener nofollow" target="_blank">Lydia Beaudette</a>, manager of growth at <a href="https://lmcmannaresearch.com/" rel="noreferrer noopener nofollow" target="_blank">LMC Manna Research</a>, discusses her role in implementing new technologies for large site networks against the backdrop of COVID-19 as well as what’s essential evaluating solution partners.“If you can get the right fit from the beginning, it can make for a much smoother process. Any technology that can be used intuitively and require minimal training is ideal.”